Does the pricing of NOK 3.30 per share represent a discount or premium relative to the current market price?

Discount or Premium?

Based on the most recent price data (as of the close on 14 August 2025) IDEX Biometrics (IDEX) is trading around NOK 3.55–3.60 per share on the Oslo exchange. The private‑placement price of NOK 3.30 therefore represents roughly a 5–8 % discount to the prevailing market level (≈ NOK 3.55). The discount widens modestly when adjusted for the average daily volume (≈ 1 M shares) and the typical intraday range, which has been confined to NOK 3.40–NOK 3.70 over the past two weeks.

Trading implications – The discount signals a potential entry point for investors who view the placement as a short‑term catalyst, especially if the dilution impact is limited (the issuance adds ~0.9 % to the free‑float). However, the price discount also reflects the market’s pricing of the upcoming dilution and the insider’s willingness to sell. A prudent approach is to buy on pull‑backs toward the lower end of the current range (≈ NOK 3.40) while keeping a tight stop‑loss at the recent low (≈ NOK 3.30) to protect against a possible price‑reversal triggered by the disclosure. Conversely, if the stock holds above the placement price for several days, the discount may evaporate and the trade could shift into a premium scenario, suggesting a sell‑on‑strength strategy if you already hold the stock or a short‑term profit‑target. Monitoring the trade’s impact on the order book and any subsequent guidance from IDEX (e.g., use of proceeds) will be key to confirming whether the discount is temporary or reflects deeper valuation concerns.